Альфа-пвп: описание и особенности

It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone). Alpha-PVP crystals often have sharp edges and varying sizes.

The substance was marketed as 'legal highs' before being banned in many regions. Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions.

Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'. The onset of effects can be subtle or delayed, which may lead to accidental overdosing due to re-dosing.

Animal studies indicate that Alpha-PVP induces hyperlocomotion and aberrant or stereotypic behaviors.

Alpha-PVP and its metabolites can be detected in blood and urine postmortem. It acts as a psychostimulant with properties similar to cocaine and MDMA.

Primary causes of death linked to Alpha-PVP use include cardiac infarction and pulmonary edema. User reports indicate a transition from initial euphoria to distress and anxiety is common.

Common clinical symptoms include mydriasis (dilated pupils), diaphoresis (excessive sweating), and seizures. Oral administration results in effects appearing around 15 minutes post-ingestion and lasting up to 6 hours.

The chemical name alpha-pyrrolidinovalerophenone is synonymous with Alpha-PVP.

In animal studies, Alpha-PVP has been found to be equally potent and effective as MDPV in terms of reinforcing effects and locomotor stimulation. The European Union banned Alpha-PVP in 2015.

The duration of high is approximately 3–5 hours for most routes of administration. Hypokalemia (low potassium levels) has been observed in cases of Alpha-PVP intoxication.

Forensic analysis often uses LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to detect Alpha-PVP in biological samples. Alpha-PVP fully substitutes for methamphetamine in rats trained to distinguish it from saline, though it is less potent than methamphetamine.

Clinical manifestations of intoxication often include tachycardia (observed in 92% of cases in one study), hypertension, and hyperthermia.

Severe adverse effects include paranoia, agitation, hallucinations, delirium, and loss of motor control. Structural modifications, such as expanding the pyrrolidine ring to piperidine, significantly reduce potency at dopamine transporters.

It was placed under a temporary nationwide ban in the United States effective February 2014. Alpha-PVP acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), with weaker effects on serotonin transporters.

Conformational restriction of the structure (e.g., in aminotetralone derivatives) leads to lower efficacy compared to Alpha-PVP. Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant.

Visual appearance often includes small white or bluish translucent crystals with a shiny surface.